Media Summary: Welcome to an exciting episode of Spotlight Media Podcast. In this episode, Spotlight Media CEO David Flores sits down with ... Patents, Partnerships, New Data. These are just some of the topics Welcome to our latest TDR Exclusive - On Location at the MAPS Psychedelics Science Conference with

Discussing Mindset Pharma S 2022 - Detailed Analysis & Overview

Welcome to an exciting episode of Spotlight Media Podcast. In this episode, Spotlight Media CEO David Flores sits down with ... Patents, Partnerships, New Data. These are just some of the topics Welcome to our latest TDR Exclusive - On Location at the MAPS Psychedelics Science Conference with In today's episode of the Psychedelic Spotlight Podcast, The Psychedelic Investor sits down with James Lanthier, CEO of In our latest TDR Psychedelic Exclusive, we catch up with the CEO of There's been much excitement in the psychedelic industry this year – with great progress in drug development and the passing of ...

We spoke with James Lanthier, CEO and Joseph Araujo Chief Scientific Officer of

Photo Gallery

Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier
Mindset Pharma Halftime Report 2022
Mindset Pharma Accelerates To Phase 2 In-Patient Trial - TDR Exclusive
Can Next Generation Psychedelics Treat  Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMT
James Lanthier from Mindset Pharma at Psychedelic Capital, July 2020 | Microdose
How Mindset Pharma Dealt Partnership With Otsuka - TDR Exclusive
Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery
Mindset Pharma shares positive preclinical results on its two sets of psychedelic drug families
The Future of Psychedelic Medicines with Mindset Pharma
Q&A with James Lanthier, CEO of Mindset Pharma (MSET-CSE)
Mindset Pharma enters exclusive reseller deal with PharmAla for its pharmaceutical-grade psilocybin
Mindset Pharma (MSET) Announces Psilocybin Breakthrough Drug
Sponsored
Sponsored
View Detailed Profile
Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier

Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier

Welcome to an exciting episode of Spotlight Media Podcast. In this episode, Spotlight Media CEO David Flores sits down with ...

Mindset Pharma Halftime Report 2022

Mindset Pharma Halftime Report 2022

Patents, Partnerships, New Data. These are just some of the topics

Sponsored
Mindset Pharma Accelerates To Phase 2 In-Patient Trial - TDR Exclusive

Mindset Pharma Accelerates To Phase 2 In-Patient Trial - TDR Exclusive

Welcome to our latest TDR Exclusive - On Location at the MAPS Psychedelics Science Conference with

Can Next Generation Psychedelics Treat  Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMT

Can Next Generation Psychedelics Treat Mental Illness? | Mindset Pharma | DMT, 5-MEO-DMT

In today's episode of the Psychedelic Spotlight Podcast, The Psychedelic Investor sits down with James Lanthier, CEO of

James Lanthier from Mindset Pharma at Psychedelic Capital, July 2020 | Microdose

James Lanthier from Mindset Pharma at Psychedelic Capital, July 2020 | Microdose

James Lanthier, CEO of

Sponsored
How Mindset Pharma Dealt Partnership With Otsuka - TDR Exclusive

How Mindset Pharma Dealt Partnership With Otsuka - TDR Exclusive

In our latest TDR Psychedelic Exclusive, we catch up with the CEO of

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

Mindset Pharma discusses decision to expand into non-hallucinogenic drug discovery

Mindset Pharma

Mindset Pharma shares positive preclinical results on its two sets of psychedelic drug families

Mindset Pharma shares positive preclinical results on its two sets of psychedelic drug families

Mindset Pharma

The Future of Psychedelic Medicines with Mindset Pharma

The Future of Psychedelic Medicines with Mindset Pharma

There's been much excitement in the psychedelic industry this year – with great progress in drug development and the passing of ...

Q&A with James Lanthier, CEO of Mindset Pharma (MSET-CSE)

Q&A with James Lanthier, CEO of Mindset Pharma (MSET-CSE)

Mindset Pharma

Mindset Pharma enters exclusive reseller deal with PharmAla for its pharmaceutical-grade psilocybin

Mindset Pharma enters exclusive reseller deal with PharmAla for its pharmaceutical-grade psilocybin

Mindset Pharma

Mindset Pharma (MSET) Announces Psilocybin Breakthrough Drug

Mindset Pharma (MSET) Announces Psilocybin Breakthrough Drug

We spoke with James Lanthier, CEO and Joseph Araujo Chief Scientific Officer of

Mindset Pharma inks agreement to begin collaborating with Global Neuroscience Pharmaceutical Giant !

Mindset Pharma inks agreement to begin collaborating with Global Neuroscience Pharmaceutical Giant !

Psychedelic companies are entering

Mindset Pharma CEO says the firm's recent efforts in the psychedelic space are delivering

Mindset Pharma CEO says the firm's recent efforts in the psychedelic space are delivering

Mindset Pharma

Mindset Pharma, Next Generation Psychedelics

Mindset Pharma, Next Generation Psychedelics

James Lanthier CEO of

Mindset Pharma identifies additional drug candidates from 'Family 3' psilocybin compounds

Mindset Pharma identifies additional drug candidates from 'Family 3' psilocybin compounds

Mindset Pharma

Mindset Pharma receives Notice of Allowance for psilocin derivatives patent application

Mindset Pharma receives Notice of Allowance for psilocin derivatives patent application

Mindset Pharma

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

Management of Mindset Pharma Educates us on the Basics of Psychedelic Patents!!!

Mindset Pharma

Mindset Pharma: Shareholder Value in Psychedelics

Mindset Pharma: Shareholder Value in Psychedelics

We caught up with James Lanthier, CEO of

Mindset Pharma chooses pair of psychedelic drug candidates to move Family 2 program forward

Mindset Pharma chooses pair of psychedelic drug candidates to move Family 2 program forward

Mindset Pharma

Related Video Content

DISCUSS Definition & Meaning - Merriam-Webster information

6 days ago · The meaning of DISCUSS is to talk about. How to use discuss in a sentence. Synonym Discussion of...

DISCUSSING | English meaning - Cambridge Dictionary information

DISCUSSING definition: 1. present participle of discuss 2. to talk about a subject with someone and tell each other...

DISCUSSING definition in American English | Collins English Dictionary information

DISCUSSING definition: to have a conversation about; consider by talking over; debate | Meaning, pronunciation,...

Discussing - definition of discussing by The Free Dictionary information

Define discussing. discussing synonyms, discussing pronunciation, discussing translation, English dictionary...

discuss verb - Definition, pictures, pronunciation and usage notes ... information

Definition of discuss verb in Oxford Advanced American Dictionary. Meaning, pronunciation, picture, example...